NAVELBINE (Pierre Fabre Pharmaceuticals, Inc.)


Welcome to the PulseAid listing for the NAVELBINE drug offered from Pierre Fabre Pharmaceuticals, Inc.. This Vinca Alkaloid [EPC],Vinca Alkaloids [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Pierre Fabre Pharmaceuticals, Inc.
NON-PROPRIETARY NAME: Vinorelbine tartrate
SUBSTANCE NAME: VINORELBINE TARTRATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Vinca Alkaloid [EPC],Vinca Alkaloids [Chemical/Ingredient]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2005-11-15
END MARKETING DATE: 0000-00-00


NAVELBINE HUMAN PRESCRIPTION DRUG Details:

Item DescriptionNAVELBINE from Pierre Fabre Pharmaceuticals, Inc.
LABELER NAME: Pierre Fabre Pharmaceuticals, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 10(mg/mL)
START MARKETING DATE: 2005-11-15
END MARKETING DATE: 0000-00-00
PRODUCT ID: 64370-532_3f002c72-3343-4707-a2a6-7ae87aa336b0
PRODUCT NDC: 64370-532
APPLICATION NUMBER: NDA020388

Other VINORELBINE TARTRATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Hospira, Inc.VINORELBINE
Pierre Fabre Pharmaceuticals, Inc.NAVELBINE
Sagent PharmaceuticalsVinorelbine
Teva Parenteral Medicines, Inc.Vinorelbine
Wyeth Pharmaceuticals Companyvinorelbine tartrate